CEREXA INC.
Cerexa is a biopharmaceutical company focused on the development of a portfolio of novel anti-infective therapies for the treatment of serious and life-threatening infections. The company’s product portfolio includes Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens.
CEREXA INC.
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2005-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
5001+
Status:
Active
Contact:
(510)285-9200
Total Funding:
50 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Cerexa Inc.
OrbiMed
OrbiMed investment in Series A - Cerexa Inc.
Montreux Equity Partners
Montreux Equity Partners investment in Series A - Cerexa Inc.
EGS Healthcare Capital Partners
EGS Healthcare Capital Partners investment in Series A - Cerexa Inc.
Canaan Partners
Canaan Partners investment in Series A - Cerexa Inc.
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series A - Cerexa Inc.
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series A - Cerexa Inc.
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - Cerexa Inc.
Domain Associates
Domain Associates investment in Series A - Cerexa Inc.